Sebia Acquires Orgentec Diagnostika

The strategic acquisition reinforces Sebia’s global leadership in specialty diagnostics LISSES, France, June 30, 2021 /PRNewswire/ — Sebia, a leading provider of clinical protein electrophoresis equipment and reagents for diabetes and oncology detection, today announced the acquisition…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.